Senior Therapeutic Area Specialist, Cardiovascular Community - Boston Central, MA at Bristol-Myers Squibb

Boston, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Field-based role requiring 100% time spent with external customers in the defined territory (Boston Central, MA)
High level of scientific expertise in assigned BMS products and cardiovascular therapeutic areas
Strong professional credibility with regional thought leaders (RTLs), community-based physicians/HCPs, private practices, medical groups, office staff, and stakeholders
Ability to engage HCPs with differentiated Customer Experience (Cx) through deeper scientific dialogue consistent with label, using tools like CE^3
Capability to prepare and implement comprehensive territory and account plans
Knowledge of emerging data for approved indications and approved scientific resources/publications
Compliance with promoting approved indications in a balanced, medically accurate manner

Responsibilities

Promote approved indications of BMS products within the territory to meet or exceed sales targets compliantly
Create demand for BMS medicines by articulating clinical and scientific rationale for appropriate patients
Maintain and grow scientific expertise in assigned products and therapeutic areas
Prepare and implement comprehensive territory and account plans; proactively use tools like CE^3 for insights and dynamic call plans
Provide feedback on tool usage to leadership for continuous improvement
Demonstrate scientific expertise in fair and balanced scientific dialogue using approved resources; conduct in-office presentations (e.g., lunch and learns)
Organize external speaker programs using approved Speakers Bureau list, handling scheduling and logistics
Engage real-time medical support via Medical on Call for unsolicited questions and complex inquiries
Proactively collaborate with other field teams to ensure optimal Customer Experience (Cx) for HCPs
Prioritize safe and appropriate use of BMS products while focusing on business results, performance objectives, and BMS values

Skills

Customer Engagement

Scientific Dialogue

HCP Interaction

Therapeutic Area Expertise

Cardiovascular Medicine

Demand Generation

Thought Leader Engagement

Customer Experience

Pharmaceutical Sales

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free